ARTICLE | Company News

SciClone, Schering-Plough infectious news

April 17, 2006 7:00 AM UTC

SCLN and SGP resolved a dispute related to trials of SCLN's Zadaxin to treat HBV that were run by SGP's Schering Plough KK subsidiary. In its 2005 annual report, SCLN said it cannot seek Japanese app...